1. Home
  2. Bills
  3. H.R. 1266

H.R. 1266 · 119th Congress · 2025–2026

Combating Illicit Xylazine Act

H.R. 1266 in the 119th Congress (2025–2026) has passed the house — introduced on Feb 12, 2025, sponsored by Jimmy Panetta with 114 co-sponsors.

During the 119th Congress (2025–2026), Donald Trump was president, and Republicans held majorities in both the House and Senate.

Status
Passed the House
Introduced
Feb 12, 2025
Co-sponsors
114
Policy area
Crime and Law Enforcement

What it does

Combating Illicit Xylazine Act This bill regulates xylazine under the Controlled Substances Act (CSA). Xylazine, also known as tranq , is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Jimmy Panetta (D-CA). Co-sponsors: 51 Democrats, 63 Republicans.

Where it stands

  • IntroducedFeb 12, 2025
  • Passed the HouseSep 15, 2026
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623. (Sep 16, 2026)

More bills from Jimmy Panetta in the 119th Congress

Other Crime and Law Enforcement bills in the 119th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 1266 (119th Congress): Combating Illicit Xylazine Act,” https://www.capitolreceipts.com/bill/119-hr-1266/combating-illicit-xylazine-act (accessed 2026-10-14).

Open the interactive version ›